PERSANTINE Drug Patent Profile
✉ Email this page to a colleague
When do Persantine patents expire, and when can generic versions of Persantine launch?
Persantine is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Persantine
A generic version of PERSANTINE was approved as dipyridamole by BARR on October 3rd, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERSANTINE?
- What are the global sales for PERSANTINE?
- What is Average Wholesale Price for PERSANTINE?
Summary for PERSANTINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 148 |
| Clinical Trials: | 9 |
| Patent Applications: | 4,208 |
| What excipients (inactive ingredients) are in PERSANTINE? | PERSANTINE excipients list |
| DailyMed Link: | PERSANTINE at DailyMed |
Recent Clinical Trials for PERSANTINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Guo-Qing Jiang | N/A |
| Peking University First Hospital | Phase 1/Phase 2 |
| Affiliated Hospital of Yunnan University of Traditional Chinese Medicine | Phase 1/Phase 2 |
US Patents and Regulatory Information for PERSANTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-003 | Dec 22, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-004 | Feb 6, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-005 | Feb 6, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
